Despite narrowing its losses significantly in 2013, Aurora Diagnostics, the Florida-based molecular laboratory, is the latest company in the sector to report ongoing struggles with maintaining revenue streams in the face of declining reimbursements. Aurora reported a net loss of $73 million on revenue of $248.2 million for calendar 2013. That’s less than half the…
Aurora Diagnostics Is Feeling the Reimbursement Heat
Despite narrowing its losses significantly in 2013, Aurora Diagnostics, the Florida-based molecular laboratory, is the latest company in the sector to report ongoing struggles with maintaining revenue streams in the face of declining reimbursements. Aurora reported a net loss of $73 million on revenue of $248.2 million for calendar 2013. That’s less than half the […]